Geometrical measures obtained from pretreatment postcontrast T1 weighted mris predict survival benefits from bevacizumab in glioblastoma patients

  1. Molina, D.
  2. Pérez-Beteta, J.
  3. Martínez-González, A.
  4. Sepúlveda, J.M.
  5. Peralta, S.
  6. Gil-Gil, M.J.
  7. Reynes, G.
  8. Herrero, A.
  9. De Las Peñas, R.
  10. Luque, R.
  11. Capellades, J.
  12. Balaña, C.
  13. Pérez-García, V.M.
Aldizkaria:
PLoS ONE

ISSN: 1932-6203

Argitalpen urtea: 2016

Alea: 11

Zenbakia: 8

Mota: Artikulua

DOI: 10.1371/JOURNAL.PONE.0161484 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak